SION

Sionna Therapeutics, Inc.

HealthcareBiotechnologyUSUSDPeers →

$35.92

LiveJun 12, 2026

AI Brief

Market cap

$1.62B

52w range

13.51 – 48.45

P / E

—

EPS

—

Volume

189.64K

Revenue · FY

—

Overview Fundamentals Market Ownership & flow Narrative & AI

Ratios Multiples Profile

Explain this page

Arphra AIPlain-English read on Sionna Therapeutics, Inc.’s valuation

Business description

· company · SEC profile

Sionna Therapeutics, Inc.

Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.

Founded

—

IPO

Feb 07, 2025

Employees

Waltham, MA

CEO

Michael Cloonan

CFO

—

Exchange

NASDAQ

Fiscal year

—

Identifiers

· company_identifiers

CIK0002036042

CUSIP829401108

ISINUS8294011080

FIGISION US

LEI—